Skip to main content
Lisa Dunkle, MD, Pediatric Infectious Disease, Madison, CT

LisaMDunkleMDFAAP, FIDSA

Pediatric Infectious Disease Madison, CT

Vice President, Global Medical Lead for coronavirus vaccine, Novavax, Inc

Dr. Dunkle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dunkle's full profile

Already have an account?

  • Office

    12 Richborough Road
    Madison, CT 06443

Summary

  • Dr. Lisa Dunkle is a pediatric infectious disease specialist in Meriden, CT. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 45 years. She is experienced in influenza, pediatric hiv/aids, pediatric infectious disease, clinical research, and anti-hiv agents.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1972 - 1976
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1972

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1989 - 2025
  • MO State Medical License
    MO State Medical License 1976 - 2025
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Distinguished Alumna Award Johns Hopkins School of Medicine, 2011

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Power of Diversity in Clinical Trials
    The Power of Diversity in Clinical TrialsMarch 6th, 2023
  • Covid-19: NVX-CoV2373 Vaccine Highly Effective in PREVENT-19 Trial
    Covid-19: NVX-CoV2373 Vaccine Highly Effective in PREVENT-19 TrialDecember 17th, 2021
  • Tribes Were Often Overlooked in COVID-19 Vaccine Trials, Frustrating Indigenous Leaders
    Tribes Were Often Overlooked in COVID-19 Vaccine Trials, Frustrating Indigenous LeadersMay 25th, 2021
  • Join now to see all

Professional Memberships